BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of Hypercholesterolemia

Reuters11-26 21:08

Nov 26 (Reuters) - Esperion Therapeutics Inc ESPR.O:

OTSUKA SUBMITS NEW DRUG APPLICATION IN JAPAN FOR BEMPEDOIC ACID IN THE TREATMENT OF HYPERCHOLESTEROLEMIA
ESPERION THERAPEUTICS INC - NO SERIOUS ADVERSE EVENTS OBSERVED IN BEMPEDOIC ACID TRIAL

Source text: ID:nGNX9ZL4zQ

Further company coverage: ESPR.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2486077491?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-26 21:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2486077491","market":"us","top_or_hot":-1,"title":"BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of Hypercholesterolemia","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of Hypercholesterolemia</title></head><body><p><span>Nov 26 (Reuters)</span><span> - </span>Esperion <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Inc <span>ESPR.O</span>:</p><ul><li><p>OTSUKA SUBMITS NEW DRUG APPLICATION IN JAPAN FOR BEMPEDOIC ACID IN THE TREATMENT OF HYPERCHOLESTEROLEMIA</p></li><li><p>ESPERION THERAPEUTICS INC - NO SERIOUS ADVERSE EVENTS OBSERVED IN BEMPEDOIC ACID TRIAL</p></li></ul><p>Source text: <span>ID:nGNX9ZL4zQ</span></p><p>Further company coverage: <span>ESPR.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of Hypercholesterolemia</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of Hypercholesterolemia\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-26 21:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA3FZWWS:1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of HypercholesterolemiaNov 26 (Reuters) - Esperion Therapeutics Inc ESPR.O:OTSUKA SUBMITS NEW DRUG APPLICATION IN...</p>\n\n<a href=\"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA3FZWWS:1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ESPR","symbol_name":"Esperion Therapeutics Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241126:nTUA3FZWWS:1","article_id":"2486077491","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2486077491","pubTimestamp":1732626481,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of HypercholesterolemiaNov 26 (Reuters) - Esperion Therapeutics Inc ESPR.O:OTSUKA SUBMITS NEW DRUG APPLICATION IN","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ESPR":"Esperion Therapeutics Inc.","BK4007":"制药"},"translate_title":"BRIEF-Otsuka在日本提交Bempedoic Acid治疗高胆固醇血症的新药申请","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ESPR":0.9},"content_text":"BRIEF-Otsuka Submits New Drug Application In Japan For Bempedoic Acid In The Treatment Of HypercholesterolemiaNov 26 (Reuters) - Esperion Therapeutics Inc ESPR.O:OTSUKA SUBMITS NEW DRUG APPLICATION IN JAPAN FOR BEMPEDOIC ACID IN THE TREATMENT OF HYPERCHOLESTEROLEMIAESPERION THERAPEUTICS INC - NO SERIOUS ADVERSE EVENTS OBSERVED IN BEMPEDOIC ACID TRIALSource text: ID:nGNX9ZL4zQFurther company coverage: ESPR.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486077491"}